CymaBay Announces the Retirement of President and Chief Executive Officer, Harold Van Wart, Ph.D.
Mar 29, 2017 12:05 pm UTC| Business
NEWARK, Calif., March 29, 2017 -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company developing therapies for specialty and orphan diseases with high unmet medical need, today announced...
CymaBay Announces the Retirement of President and Chief Executive Officer, Harold Van Wart, Ph.D.
Mar 29, 2017 12:05 pm UTC| Business
NEWARK, Calif., March 29, 2017 -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company developing therapies for specialty and orphan diseases with high unmet medical need, today announced...
Firma's Grace Point Mining Corp and MX Gold Corp Advance Magistral Project
Mar 29, 2017 12:05 pm UTC| Business
VANCOUVER, B.C., March 29, 2017 -- MX Gold Corp. (TSX-V:MXL) (FSE:ODV) (OTCQX:MXLGF)(“MX Gold” or the “Company”) is pleased to announce that the Magistral Management Committee, which manages the Company’s partnership...
CymaBay Announces the Retirement of President and Chief Executive Officer, Harold Van Wart, Ph.D.
Mar 29, 2017 12:05 pm UTC| Business
NEWARK, Calif., March 29, 2017 -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company developing therapies for specialty and orphan diseases with high unmet medical need, today announced...
CymaBay Announces the Retirement of President and Chief Executive Officer, Harold Van Wart, Ph.D.
Mar 29, 2017 12:05 pm UTC| Business
NEWARK, Calif., March 29, 2017 -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company developing therapies for specialty and orphan diseases with high unmet medical need, today announced...
Mar 29, 2017 12:04 pm UTC| Business
NEW YORK, March 29, 2017 -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative...
CymaBay Announces the Retirement of President and Chief Executive Officer, Harold Van Wart, Ph.D.
Mar 29, 2017 12:04 pm UTC| Business
NEWARK, Calif., March 29, 2017 -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company developing therapies for specialty and orphan diseases with high unmet medical need, today announced...